Delayed Prostate Cancer Therapy Syosset NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Louis Juden Reed
(718) 863-8465
1180 Morris Park Ave
Bronx, NY
Farida P Chaudhri MD
(718) 358-3057
146-01 45th Ave
Flushing, NY
Michael Edward Garrison, MD
516-572-8891
2201 Hempstead Tpke
East Meadow, NY
Kee-Yee Shum, MD
718-463-2245
13625 Maple Ave Ste 205
Flushing, NY
Steven Lee Allen, MD
516-562-8959
300 Community Dr
Manhasset, NY
Zahra Shafaee
(516) 632-3350
1 S Central Ave
Valley Stream, NY
Steven Edward Vogl
(718) 519-7774
2220 Tiemann Ave
Bronx, NY
KLAUS DITTMAR, MD
(516) 627-1221
1201 Northern Boulevard
Manhasset, NY
Mamta Tarak Choksi, MD
718-883-3000 x195
6 Station Rd
Mineola, NY
Morton R Axelrod, MD
718-793-0221
72 47 139th St
Flushing, NY
Data Provided by:
      

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Attack Of The Cancer Fighting Tomatoes Syosset NY
The active ingredient that makes tomatoes such a formidable opponent against cancer cells is the carotenoid called Lycopene. Lycopene is the natural red pigment found in tomatoes and tomato based products. The redder the tomato, the more lycopene is present. Read on and learn more.
- Hormone Therapy for Early Prostate Cancer Syosset NY
- Hormone Therapy for Prostate Cancer Syosset NY
- Hormone Therapy for Breast Cancer Syosset NY
- Head and Neck Cancer Treatment Syosset NY
- Drug Combo Proves Powerful Against Lung Cancer Syosset NY
- Exercise for Prostate Cancer Syosset NY
- Open Prostatectomy Versus Laparoscopic Procedure Syosset NY
- Hormone Therapy for Lung Cancer Syosset NY
- Diagnosis of Prostate Cancer Syosset NY